Related references
Note: Only part of the references are listed.The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a FcγRI-dependent manner
Daniela Tudor et al.
AIDS (2011)
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
Morgane Bomsel et al.
IMMUNITY (2011)
Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies
Peter Rusert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
A Trimeric, V2-Deleted HIV-1 Envelope Glycoprotein Vaccine Elicits Potent Neutralizing Antibodies but Limited Breadth of Neutralization in Human Volunteers
Paul Spearman et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Two Closely Related Env Antigens from the Same Patient Elicited Different Spectra of Neutralizing Antibodies against Heterologous HIV-1 Isolates
Michael Vaine et al.
JOURNAL OF VIROLOGY (2011)
The V1V2 Domain and an N-Linked Glycosylation Site in the V3 Loop of the HIV-1 Envelope Glycoprotein Modulate Neutralization Sensitivity to the Human Broadly Neutralizing Antibody 2G12
Antoine Chaillon et al.
JOURNAL OF VIROLOGY (2011)
Broadly Cross-Neutralizing Antibodies in HIV-1 Patients with Undetectable Viremia
M. Medina-Ramirez et al.
JOURNAL OF VIROLOGY (2011)
Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic
Zelda Euler et al.
JOURNAL OF VIROLOGY (2011)
Cross-Clade HIV-1 Neutralizing Antibodies Induced with V3-Scaffold Protein Immunogens following Priming with gp120 DNA
Susan Zolla-Pazner et al.
JOURNAL OF VIROLOGY (2011)
Direct Antibody Access to the HIV-1 Membrane-Proximal External Region Positively Correlates with Neutralization Sensitivity
B. K. Chakrabarti et al.
JOURNAL OF VIROLOGY (2011)
Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop
Penny L. Moore et al.
JOURNAL OF VIROLOGY (2011)
The Breadth and Potency of Passively Acquired Human Immunodeficiency Virus Type 1-Specific Neutralizing Antibodies Do Not Correlate with the Risk of Infant Infection
John B. Lynch et al.
JOURNAL OF VIROLOGY (2011)
The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection
Elin S. Gray et al.
JOURNAL OF VIROLOGY (2011)
The Genetic Bottleneck in Vertical Transmission of Subtype C HIV-1 Is Not Driven by Selection of Especially Neutralization-Resistant Virus from the Maternal Viral Population
Elizabeth S. Russell et al.
JOURNAL OF VIROLOGY (2011)
Sequential Immunization with a Subtype B HIV-1 Envelope Quasispecies Partially Mimics the In Vivo Development of Neutralizing Antibodies
Delphine C. Malherbe et al.
JOURNAL OF VIROLOGY (2011)
Isolation of a Monoclonal Antibody That Targets the Alpha-2 Helix of gp120 and Represents the Initial Autologous Neutralizing-Antibody Response in an HIV-1 Subtype C-Infected Individual
Elin S. Gray et al.
JOURNAL OF VIROLOGY (2011)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Clade and Elicits T-Cell Immunity in Macaques Mucosally Challenged with an R5 Clade C SHIV
Jennifer D. Watkins et al.
PLOS ONE (2011)
HIV-1 gp41 Core with Exposed Membrane-Proximal External Region Inducing Broad HIV-1 Neutralizing Antibodies
Ji Wang et al.
PLOS ONE (2011)
A Directed Molecular Evolution Approach to Improved Immunogenicity of the HIV-1 Envelope Glycoprotein
Sean X. Du et al.
PLOS ONE (2011)
Induction of HIV Neutralizing Antibodies against the MPER of the HIV Envelope Protein by HA/gp41 Chimeric Protein-Based DNA and VLP Vaccines
Ling Ye et al.
PLOS ONE (2011)
Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody
Dennis R. Burton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: Efficacy against repeated mucosal R5 clade C SHIV challenges
Samir K. Lakhashe et al.
VACCINE (2011)
Enhanced Mucosal Immune Responses to HIV Virus-Like Particles Containing a Membrane-Anchored Adjuvant
Elena V. Vassilieva et al.
MBIO (2011)
Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
Iliyana Mikell et al.
PLOS PATHOGENS (2011)
A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity
Joshua S. Klein et al.
AIDS (2010)
The Role of Antibodies in HIV Vaccines
John R. Mascola et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Toward an Antibody-Based HIV-1 Vaccine
James A. Hoxie
ANNUAL REVIEW OF MEDICINE (2010)
Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
M. Juliana McElrath et al.
IMMUNITY (2010)
Pseudovirion Particles Bearing Native HIV Envelope Trimers Facilitate a Novel Method for Generating Human Neutralizing Monoclonal Antibodies Against HIV
Mark D. Hicar et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Stabilized HIV-1 Envelope Glycoprotein Trimers Lacking the V1V2 Domain, Obtained by Virus Evolution
Ilja Bontjer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
HIV Neutralizing Antibodies: Clinical Correlates and Implications for Vaccines
Nicole A. Doria-Rose
JOURNAL OF INFECTIOUS DISEASES (2010)
Cross-Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression
Zelda Euler et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Comparative Immunogenicity of Subtype A Human Immunodeficiency Virus Type 1 Envelope Exhibiting Differential Exposure of Conserved Neutralization Epitopes
Catherine A. Blish et al.
JOURNAL OF VIROLOGY (2010)
Envelope Vaccination Shapes Viral Envelope Evolution following Simian Immunodeficiency Virus Infection in Rhesus Monkeys
Aravind Basavapathruni et al.
JOURNAL OF VIROLOGY (2010)
Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables
Nicole A. Doria-Rose et al.
JOURNAL OF VIROLOGY (2010)
Long-Lasting Protective Antiviral Immunity Induced by Passive Immunotherapies Requires both Neutralizing and Effector Functions of the Administered Monoclonal Antibody
Roudaina Nasser et al.
JOURNAL OF VIROLOGY (2010)
Constraints on HIV-1 Diversity from Protein Structure
Jeongmin Woo et al.
JOURNAL OF VIROLOGY (2010)
A Limited Number of Simian Immunodeficiency Virus (SIV) env Variants Are Transmitted to Rhesus Macaques Vaginally Inoculated with SIVmac251
Mars Stone et al.
JOURNAL OF VIROLOGY (2010)
Multiple Vaccine-Elicited Nonneutralizing Antienvelope Antibody Activities Contribute to Protective Efficacy by Reducing both Acute and Chronic Viremia following Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques
Peng Xiao et al.
JOURNAL OF VIROLOGY (2010)
Ablation of the Complementarity-Determining Region H3 Apex of the Anti-HIV-1 Broadly Neutralizing Antibody 2F5 Abrogates Neutralizing Capacity without Affecting Core Epitope Binding
Jean-Philippe Julien et al.
JOURNAL OF VIROLOGY (2010)
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
Hugo Mouquet et al.
NATURE (2010)
Targeting early infection to prevent HIV-1 mucosal transmission
Ashley T. Haase
NATURE (2010)
Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques
Cherie T. Ng et al.
NATURE MEDICINE (2010)
Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level
Evelien M. Bunnik et al.
NATURE MEDICINE (2010)
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals
Davide Corti et al.
PLOS ONE (2010)
Comparative Magnitude of Cross-Strain Conservation of HIV Variable Loop Neutralization Epitopes
James Swetnam et al.
PLOS ONE (2010)
Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions
Erin M. Scherer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates
Elisabetta Bianchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
Katie J. Doores et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Tongqing Zhou et al.
SCIENCE (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope
Bruno E. Correia et al.
STRUCTURE (2010)
Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects
D. Noah Sather et al.
VACCINE (2010)
B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection
Kuan-Hsiang G. Huang et al.
NATURE COMMUNICATIONS (2010)
Identifying and characterizing recently transmitted viruses
Brandon F. Keele
CURRENT OPINION IN HIV AND AIDS (2010)
Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
S. Gnanakaran et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
A Crucial Role for Infected-Cell/Antibody Immune Complexes in the Enhancement of Endogenous Antiviral Immunity by Short Passive Immunotherapy
Henri-Alexandre Michaud et al.
PLOS PATHOGENS (2010)
HIV-1 Envelope Subregion Length Variation during Disease Progression
Marcel E. Curlin et al.
PLOS PATHOGENS (2010)
Contribution of Nonneutralizing Vaccine-Elicited Antibody Activities to Improved Protective Efficacy in Rhesus Macaques Immunized with Tat/Env Compared with Multigenic Vaccines
Ruth H. Florese et al.
JOURNAL OF IMMUNOLOGY (2009)
Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals
Yuxing Li et al.
JOURNAL OF VIROLOGY (2009)
Continuous Viral Escape and Selection by Autologous Neutralizing Antibodies in Drug-Naive Human Immunodeficiency Virus Controllers
Madhumita Mahalanabis et al.
JOURNAL OF VIROLOGY (2009)
A Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing Antibodies
Robert Pejchal et al.
JOURNAL OF VIROLOGY (2009)
Breadth of Neutralizing Antibody Response to Human Immunodeficiency Virus Type 1 Is Affected by Factors Early in Infection but Does Not Influence Disease Progression
Anne Piantadosi et al.
JOURNAL OF VIROLOGY (2009)
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Johannes F. Scheid et al.
NATURE (2009)
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
Ann J. Hessell et al.
NATURE MEDICINE (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Role of HIV membrane in neutralization by two broadly neutralizing antibodies
S. Munir Alam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Laura M. Walker et al.
SCIENCE (2009)
Maternal neutralizing antibodies against a CRF01_AE primary isolate are associated with a low rate of intrapartum HIV-1 transmission
Tanawan Samleerat et al.
VIROLOGY (2009)
Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection
Penny L. Moore et al.
PLOS PATHOGENS (2009)
Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways
Rong Rong et al.
PLOS PATHOGENS (2009)
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
Ann J. Hessell et al.
PLOS PATHOGENS (2009)
Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope
Susan W. Barnetta et al.
AIDS (2008)
The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: Dominant site of antibody neutralization and target for vaccine design
Marinieve Montero et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2008)
Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection
Brandon F. Keele et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers
Shixia Wang et al.
VACCINE (2008)
Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge
Willy M. J. M. Bogers et al.
VIROLOGY (2008)
Transmission of HIV-1 in the face of neutralizing antibodies
Catherine A. Blish et al.
CURRENT HIV RESEARCH (2007)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
Structural definition of a conserved neutralization epitope on HIV-1 gp120
Tongqing Zhou et al.
NATURE (2007)
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41
RMF Cardoso et al.
IMMUNITY (2005)
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
JA Binley et al.
JOURNAL OF VIROLOGY (2004)
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
DA Calarese et al.
SCIENCE (2003)
Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies
Y Nishimura et al.
JOURNAL OF VIROLOGY (2002)
Share Paper
